Sterling Capital cuts Merck stake by 39.5%
Alpha Vantage · MarketBeat · · AI-summarised by FinFlash
Sterling Capital Management LLC cut its Merck & Co. stake by 39.5% in the third quarter, selling 42,781 shares and keeping 65,526 shares worth about $9.5 million. Institutions still hold 76.07% of MRK, and analysts maintain a Moderate Buy consensus with an average price target of Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context